Investing Center Preview – Manage your investments and watch your net worth grow.
SYK:NYSE – Large Cap Stock (Medical Devices)
Stryker Corp – SYK Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
345.80 | -22.35 (-6.07%) | 314.93 - 406.19 | 4.0 million (Above Avg) |
Market data as of 3:59PM 04/04/25. Quotes are delayed by at least 15 min.
Overview - SYK
Open | 361.08 |
---|---|
Previous Close | 368.15 |
Day's Range | 344.81 - 362.07 |
Market Cap | 132.0B |
Avg Volume (10 Day) | 1.8M |
Price/Earnings (Trailing 12 Mo.) | 47.4x |
Earnings Per Share (Trailing 12 Mo.) | 2.739 |
Dividend Yield | 0.84 (0.97%) |
One-Click Scorecard - SYK


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Pass |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Pass |
Shareholder's money handled rationally? | Pass |
Increased shareholder value? | Fail |
Consistently increased owner earnings? | Pass |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Pass |
---|---|
Room to increase dividends? | Pass |
Increased earnings over time? | Pass |
Borrows within reasonable limits? | Fail |
Stock is undervalued? | Fail |
Have investors caught on? | Fail |
Has support of institutional investors? | Pass |
Has sufficient liquidity? | Pass |
Latest Headlines - SYK
Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting
PR Newswire - Tuesday 03/11/2025 8:03 AM ET
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases
PR Newswire - Thursday 03/06/2025 1:36 PM ET
Industry Position - SYK
SYK | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 10.23% | |
Net Income Growth (1yr) | -5.43% | |
Total Debt/Equity | 0.66 | |
LT Debt/Equity | 0.59 | |
Earnings Yield | 2.11% | |
Price/Sales | 6.28 |
Competitors - SYK
Company | Last | Change |
---|---|---|
14720.00 | +0.14% | |
963.00 | -2.43% | |
6830.00 | +0.15% | |
Boston Scientific Corp | 89.70 | -8.93% |
1851.00 | +1.76% |
Data is delayed by at least 15 min.